Metabolism - Clinical and Experimental
Volume 55, Issue 12 , Pages 1574-1581 , December 2006

Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study

  • D. Michael Hallman

      Affiliations

    • Human Genetics Center, University of Texas-Houston Health Science Center, Houston, TX 77225, USA
    • Corresponding Author InformationCorresponding author. Human Genetics Center, University of Texas-Houston, School of Public Health, PO Box 20334, Houston, TX 77225, USA. Tel.: +1 713 500 9893; fax: +1 713 500 0900.
    • ,
  • Sathanur R. Srinivasan

      Affiliations

    • Tulane Center for Cardiovascular Health, Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA
    • ,
  • Wei Chen

      Affiliations

    • Tulane Center for Cardiovascular Health, Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA
    • ,
  • Eric Boerwinkle

      Affiliations

    • Human Genetics Center, University of Texas-Houston Health Science Center, Houston, TX 77225, USA
    • Institute of Molecular Medicine, University of Texas-Houston Health Science Center, Houston, TX 77225, USA
    • ,
  • Gerald S. Berenson

      Affiliations

    • Tulane Center for Cardiovascular Health, Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA

Received 8 February 2006 ,Accepted 24 July 2006.

References 

  1. Pennacchio LA, Olivier M, Hubacek JA, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001;294:169–173
  2. Talmud PJ, Hawe E, Martin S, et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet. 2002;11:3039–3046
  3. Horínek A, Vráblík M, Ceska R, et al. T-1131→C polymorphism with the apolipoprotein AV gene in hypertriglyceridemic individuals. Atherosclerosis. 2003;167:369–370
  4. Martin S, Nicaud V, Humphries SE, et al. Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges. Biochim Biophys Acta. 2003;1637:217–225
  5. Jang Y, Kim JY, Kim OY, et al. The −1131 T→C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men. Am J Clin Nutr. 2004;80:832–840
  6. Pennacchio LA, Olivier M, Hubacek JA, et al. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet. 2002;11:3031–3038
  7. Evans D, Buchwald A, Beil FU. The single nucleotide polymorphism −1131T→C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia. J Mol Med. 2003;81:645–654
  8. Lai C-Q, Demissie S, Cupples LA, et al. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res. 2004;45:2096–2105
  9. Lai C-Q, Tai E-S, Tan CE, et al. The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res. 2003;44:2365–2373
  10. Shachter NS. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol. 2001;12:297–304
  11. Surguchov AP, Page GP, Smith L, et al. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 1996;16:941–947
  12. Groenendijk M, Cantor RM, de Bruin TWA, et al. The apoAI-CIII-AIV gene cluster. Atherosclerosis. 2001;157:1–11
  13. Minihane AM, Finnegan YE, Talmud P, et al. Influence of the APOC3 −2854T→G polymorphism on plasma lipid levels: effect of age and gender. Biochim Biophys Acta. 2002;1583:311–314
  14. Waterworth DM, Ribalta J, Nicaud V, et al. ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests. Circulation. 1999;99:1872–1877
  15. Waterworth DM, Talmud PJ, Bujac SR, et al. Contribution of apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men. Arterioscler Thromb Vasc Biol. 2000;20:2663–2669
  16. Berenson GS, McMahan CA, Voors AW, et al. Cardiovascular risk factors in children. The early natural history of atherosclerosis and essential hypertension. New York: Oxford University Press; 1980;
  17. Lipid Research Clinics Program . Manual of laboratory operations vol. I: lipid and lipoprotein analysis. DHEW publication no. (NIH) 75-628 Washington (DC): National Institutes of Health; 1974;
  18. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:476–482
  19. Allain CC, Poon LS, Chan CSG, et al. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470–475
  20. Srinivasan SR, Berenson GS. Serum lipoproteins in children and methods for study. In:  Lewis LA,  Opplt JJ editor. CRC handbook on electrophoresis. Lipoprotein methodology and human studies. vol 3:Boca Raton (Fla): CRC Press; 1983;p. 185–204
  21. Hallman DM, Srinivasan SR, Elkasabany A, et al. The Ser447-Stop polymorphism of lipoprotein lipase is associated with variation in longitudinal serum high-density lipoprotein-cholesterol profiles: The Bogalusa Heart Study. Metabolism. 2001;50:894–904
  22. Hallman DM, Srinivasan SR, Chen W, et al. The β2-adrenergic receptor Arg16-Gly polymorphism and interactions involving β2- and β3-adrenergic receptor polymorphisms are associated with variations in longitudinal serum lipid profiles: The Bogalusa Heart Study. Metabolism. 2004;53:1184–1191
  23. Zaykin DV, Westfall PH, Young SS, et al. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered. 2002;53:79–91
  24. Olivier M, Wang X, Cole R, et al. Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Genomics. 2004;83:912–923
  25. Talmud PJ, Palmen J, Putt W, et al. Determination of the functionality of common APOA5 polymorphisms. J Biol Chem. 2005;280:28215–28220
  26. Fullerton SM, Buchanan AV, Sonpar VA, et al. The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster. Hum Genet. 2004;115:36–56
  27. Hallman DM, Groenemeijer BE, Jukema JW, et al. Analysis of lipoprotein lipase haplotypes reveals associations not apparent from analysis of the constituent loci. Ann Hum Genet. 1999;63:499–510
  28. Tanck MWT, Klerkx AHEM, Jukema JW, et al. Estimation of multilocus haplotype effects using weighted penalised log-likelihood: analysis of five sequence variations at the cholesteryl ester transfer protein locus. Ann Hum Genet. 2003;67:175–184
  29. Endo K, Yanagi H, Araki J, et al. Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet. 2002;111:570–572
  30. Li G-P, Wang J-Y, Yan S-K, et al. Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoprotein levels in a Chinese population. Clin Genet. 2004;65:470–476
  31. Talmud PJ, Berglund L, Hawe EM, et al. Age-related effects of genetic variation on lipid levels: The Columbia University BioMarkers Study. Pediatrics. 2001;108:E50
  32. deFrança E, Alves JGB, Hutz MH. APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children. Braz J Med Biol Res. 2005;38:535–541
  33. Merkel M, Loeffler B, Kluger M, et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem. 2005;280:21553–21560
  34. Olofsson S-O, Apo A-V. The regulation of a regulator of plasma triglycerides. Arterioscler Thromb Vasc Biol. 2005;25:1097–1099
  35. Lookene A, Beckstead JA, Nilsson S, et al. Apolipoprotein A-V–heparin interactions. Implications for plasma lipoprotein metabolism. J Biol Chem. 2005;280:25383–25387
  36. Marçais C, Verges B, Charrière S, et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J Clin Invest. 2005;115:2862–2869
  37. Vu-Dac N, Gervois P, Jakel H, et al. Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor α activators. J Biol Chem. 2003;278:17982–17985
  38. Prieur X, Coste H, Rodríguez JC. The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-α and contains a novel farnesoid X-activated receptor response element. J Biol Chem. 2003;278:25468–25480
  39. Fu J, Gaetani S, Oveisi F, et al. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α. Nature. 2003;425:90–93

PII: S0026-0495(06)00266-6

doi: 10.1016/j.metabol.2006.07.018

Metabolism - Clinical and Experimental
Volume 55, Issue 12 , Pages 1574-1581 , December 2006

Article Tools

* Image Usage & Resolution